Valion Bio VBIO Cash Flow Statement (2021-2026)

NASDAQ VBIO
$0.99 -0.13 (-11.87%)
As of: Oct 22, 2026 · 1:13 PM EDT
Reported Financials

Valion Bio Quarterly Cash Flow Statement

Periods 21 quarters
Latest Jun 2026

Valion Bio cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 21 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-1.09M-2.32M-3.72M-2.24M-3.02M-2.58M-2.25M-2.12M-2.13M-1.76M-2.24M-1.48M-1.27M-1.43M-1.50M-1.50M-1.93M-2.60M-2.87M-7.10M
Depreciation and DepletionDep. & Depletion
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.36M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.21M1.14M0.13M
Depreciation & Amortization (CF)Dep. & Amort.
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.36M
Share-based CompensationStock Comp.
0.01M0.02M0.24M0.06M0.11M0.11M0.11M0.08M0.08M0.05M0.06M0.05M0.05M0.06M0.06M0.10M0.18M0.14M0.15M0.13M
Gains from Sales and DivestituresGains Divest
-0.12M
Gains from Investment SecuritiesGains Investment
0.03M0.08M0.36M0.05M
Asset Writedowns and ImpairmentWritedown
0.34M
Other non-cash itemsOther Non-Cash
-0.19M0.00M1.80M0.05M0.04M0.04M0.04M0.04M0.04M0.04M0.05M0.05M0.01M0.02M0.27M0.05M
Change in Working Capital
Change in ReceivablesChange Receivables
0.04M0.00M0.00M0.03M0.00M-0.03M-0.04M0.12M0.02M-0.10M-0.05M-0.01M0.06M-0.06M0.01M
Change in InventoryChange Inventory
0.05M0.14M0.02M0.39M-0.07M0.10M0.08M0.05M-0.06M-0.14M0.01M0.01M-0.04M0.01M-0.01M0.01M-0.09M-16.17M
Change in Account PayablesChange Payables
0.52M0.12M-0.51M-0.16M1.29M-0.31M-0.28M-0.23M-0.26M-0.19M0.08M-0.17M-0.10M-0.11M-0.21M0.31M-0.20M0.23M-0.20M
Change in Accured ExpensesChange Accured Exp.
-0.01M0.01M-0.04M0.04M-0.01M-0.03M0.12M-0.08M-0.15M0.05M0.29M-0.23M-0.12M0.08M-0.08M0.16M0.20M-0.33M0.21M
Change in Other Operating AssetsOther Assets Change
-0.12M0.03M0.74M-0.18M-0.24M-0.07M-0.10M0.06M-0.02M-0.05M0.10M-0.08M-0.06M0.01M0.02M0.02M0.09M-0.07M-0.12M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.04M-0.04M-0.06M-0.04M-0.03M-0.05M-0.05M-0.05M-0.05M-0.03M-0.02M-0.27M
Other Working Capital ChangesOther WC Changes
0.12M-0.03M-0.74M0.14M0.19M0.01M0.05M-0.08M-0.03M0.00M-0.15M0.03M0.03M0.00M0.07M0.12M
Cash from OperationsCash from Ops.
-0.54M-1.64M-2.76M-2.20M-1.72M-2.78M-2.22M-2.43M-2.47M-1.84M-1.77M-1.70M-1.30M-1.40M-1.33M-0.90M-1.82M-2.00M-2.29M
Investing Activities
Capital ExpendituresCapex
0.01M0.01M0.09M0.02M0.01M0.03M
Change in Property, Plant and EquipmentChange in PP&E
-0.01M-0.01M-0.09M-0.02M-0.01M-0.03M
Cash from Investing ActivitiesCash from Investing
-0.01M-0.01M-0.09M-0.02M-0.53M-0.02M-0.01M-0.15M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
1.75M0.45M
Long-Term Debt RepaymentsLT Debt Repayment
0.01M
Non-Current Debt
1.74M0.45M
Net Debt Issuances and RepaymentsNet Debt Issuance
1.74M0.45M
Change in Capital Stock
Common Stock IssuedStock Issued
0.06M14.89M4.19M4.32M0.02M1.12M0.11M2.49M-0.16M
Net Shares Issued and RepurchasedNet Shares Issued
0.06M14.89M4.19M4.32M0.02M1.12M0.11M2.49M-0.16M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
3.75M11.87M
Net Equity Issued and RepurchasedNet Equity Issued
0.06M14.89M4.19M4.32M0.02M1.12M0.11M2.49M3.60M11.87M
Other financing activitiesOther financing
-0.29M0.42M0.06M0.09M-0.24M
Cash from Financing ActivitiesCash from Financing
1.57M0.87M14.89M-0.58M4.17M-0.04M4.38M-0.06M3.31M-0.10M1.18M0.08M2.36M4.27M11.63M
Additional items
Change in Cash
1.02M-0.78M12.13M-2.17M-1.75M-2.72M-2.81M1.65M-2.51M2.51M-1.77M-1.73M2.03M-1.50M-0.19M-1.33M0.52M2.27M9.20M
Ending Cash Balance
1.62M0.85M12.98M10.80M9.05M6.33M3.52M5.17M2.66M5.17M3.40M1.67M3.69M2.19M2.00M0.67M1.18M3.45M12.65M2.48M
Free Cash FlowFCF
-0.54M-1.64M-2.76M-2.21M-1.72M-2.79M-2.22M-2.52M-2.50M-1.84M-1.77M-1.70M-1.30M-1.40M-1.33M-0.90M-1.82M-2.01M-2.31M
Net Cash FlowNCF
1.02M-0.78M12.13M-2.21M-1.72M-2.79M-2.80M1.65M-2.54M2.54M-1.77M-1.76M2.01M-1.50M-0.15M-1.34M0.53M2.27M9.19M

Valion Bio Cash Flow Statement API

Pull Valion Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VBIO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY